Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Amgen describes new PRMT5 inhibitors

Sep. 9, 2021

New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences

Sep. 9, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

Bristol Myers Squibb patents rotein-arginine deiminase type-4 inhibitors

Sep. 8, 2021

New CAPN2 inhibitors identified at Western University of Health Sciences

Sep. 8, 2021

Lilly discovers TYK2 JH2 domain ligands

Sep. 8, 2021

Bahcesehir University presents new apoptosis regulator Bcl-2 inhibitors

Sep. 8, 2021

Curadev Pharma presents new STING antagonists

Sep. 7, 2021

Monoglyceride lipase inhibitors identified at Janssen

Sep. 7, 2021

Boehringer Ingelheim describes new plasma kallikrein inhibitors

Sep. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...